Aberrant DNA methylation of PTPRG as one possible mechanism of its under‐expression in CML patients...
Aberrant DNA methylation of PTPRG as one possible mechanism of its under‐expression in CML patients in the State of Qatar
About this item
Full title
Author / Creator
Ismail, Mohamed A. , Samara, Muthanna , Al Sayab, Ali , Alsharshani, Mohamed , Yassin, Mohamed A. , Varadharaj, Govindarajulu , Vezzalini, Marzia , Tomasello, Luisa , Monne, Maria , Morsi, Hisham , Qoronfleh, M. Walid , Zayed, Hatem , Cook, Richard , Sorio, Claudio , Modjtahedi, Helmout and Al‐Dewik, Nader I.
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
Several studies showed that aberrant DNA methylation is involved in leukemia and cancer pathogenesis. Protein tyrosine phosphatase receptor gamma (PTPRG) expression is a natural inhibitory mechanism that is downregulated in chronic myeloid leukemia (CML) disease. The mechanism behind its downregulation has not been fully elucidated ye...
Alternative Titles
Full title
Aberrant DNA methylation of PTPRG as one possible mechanism of its under‐expression in CML patients in the State of Qatar
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a3a4fc0e01ad4936bd8a4d7c9f95ad23
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a3a4fc0e01ad4936bd8a4d7c9f95ad23
Other Identifiers
ISSN
2324-9269
E-ISSN
2324-9269
DOI
10.1002/mgg3.1319
